The Future of the Pharmaceutical Industry is in Emerging Markets – Pharmaceutical Compliance Monitor #pharma #market #access

Posted On Jan 7 2018 by

#future of pharmaceutical industry # The Future of the Pharmaceutical Industry is in Emerging Markets When growth at home slows, smart companies expand abroad. Stagnation suffocates a company’s growth, so when profits start to level out after years of growth, smart companies immediately begin to scour the globe for new sources of revenue to move their organizations back into a more profitable position. For the pharmaceutical industry, expanding into emerging markets is inevitable and will prove to be a critical step in the industry’s evolution, despite initial growing pains. Let’s take a step back and look at the commonly accepted …


The Challenges Facing Emerging Markets Generic Pharmaceutical Companies #pharma #marketing #jobs

Posted On Dec 27 2017 by

#generic pharmaceutical companies # Additional Information: The Challenges Facing Emerging Markets Generic Pharmaceutical Companies By Thomas Ansen-Wilson The US generic drug market has been quite lucrative for EM pharma companies over the last decade. Many EM pharma companies have significantly outperformed the market by leveraging solid technological capabilities and low manufacturing costs. However, the future looks more difficult as a number of changes in the US market have made the landscape increasingly challenging. In the past, when there were fewer players in the market, the first few firms to launch a generic drug were able to generate profits for a …


The Future of the Pharmaceutical Industry is in Emerging Markets – Pharmaceutical Compliance Monitor #claris #pharma

Posted On Dec 24 2017 by

#future of pharmaceutical industry # The Future of the Pharmaceutical Industry is in Emerging Markets When growth at home slows, smart companies expand abroad. Stagnation suffocates a company’s growth, so when profits start to level out after years of growth, smart companies immediately begin to scour the globe for new sources of revenue to move their organizations back into a more profitable position. For the pharmaceutical industry, expanding into emerging markets is inevitable and will prove to be a critical step in the industry’s evolution, despite initial growing pains. Let’s take a step back and look at the commonly accepted …


The Future of the Pharmaceutical Industry is in Emerging Markets – Pharmaceutical Compliance Monitor #pharmaceutical #market #research

Posted On Dec 8 2017 by

#future of pharmaceutical industry # The Future of the Pharmaceutical Industry is in Emerging Markets When growth at home slows, smart companies expand abroad. Stagnation suffocates a company’s growth, so when profits start to level out after years of growth, smart companies immediately begin to scour the globe for new sources of revenue to move their organizations back into a more profitable position. For the pharmaceutical industry, expanding into emerging markets is inevitable and will prove to be a critical step in the industry’s evolution, despite initial growing pains. Let’s take a step back and look at the commonly accepted …


New job opportunities emerging in Big Pharma #actavis #pharma

Posted On Nov 13 2017 by

#big pharma jobs # New job opportunities emerging in Big Pharma Since 2001, 300,000 pharma employees have lost their jobs, primarily in R D and sales. That’s according to Clifford Mintz, the founder of BioInsights, which develops and offers bioscience education and training. Mintz spoke at a session on new job opportunities in biotech and pharma at the annual AAPS meeting in Washington, D.C. While the losses have been steep, they’re balanced by emerging, in-demand careers in the industry. The industry’s struggles are well-known: Many companies are facing loss of exclusivity on their biggest sellers but have little in the …


The Challenges Facing Emerging Markets Generic Pharmaceutical Companies #mayne #pharma

Posted On Nov 8 2017 by

#generic pharmaceutical companies # Additional Information: The Challenges Facing Emerging Markets Generic Pharmaceutical Companies By Thomas Ansen-Wilson The US generic drug market has been quite lucrative for EM pharma companies over the last decade. Many EM pharma companies have significantly outperformed the market by leveraging solid technological capabilities and low manufacturing costs. However, the future looks more difficult as a number of changes in the US market have made the landscape increasingly challenging. In the past, when there were fewer players in the market, the first few firms to launch a generic drug were able to generate profits for a …


CDC – ELC Cooperative Agreement – DPEI, cdc emerging infectious diseases.#Cdc #emerging #infectious #diseases

Posted On Sep 20 2017 by

# Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) Cooperative Agreement CDC s national funding strategy helps state, local, and territorial health departments battle infectious disease threats in the U.S. Over $300 million in fiscal year 2017 awarded to strengthen U.S. public health infrastructure CDC awarded over $300 million in federal fiscal year 2017 to strengthen the ability of domestic health departments to respond to infectious disease threats. This crucial CDC investment, provided through the Epidemiology and Laboratory Capacity (ELC) for Infectious Diseases Cooperative Agreement, helps local, state, and territorial health departments continue to: Build and maintain effective public health …


New job opportunities emerging in Big Pharma #choice #pharma

Posted On Sep 6 2017 by

#big pharma jobs # New job opportunities emerging in Big Pharma Since 2001, 300,000 pharma employees have lost their jobs, primarily in R D and sales. That’s according to Clifford Mintz, the founder of BioInsights, which develops and offers bioscience education and training. Mintz spoke at a session on new job opportunities in biotech and pharma at the annual AAPS meeting in Washington, D.C. While the losses have been steep, they’re balanced by emerging, in-demand careers in the industry. The industry’s struggles are well-known: Many companies are facing loss of exclusivity on their biggest sellers but have little in the …


New job opportunities emerging in Big Pharma #dr #reddy #pharma

Posted On Aug 15 2017 by

#big pharma jobs # New job opportunities emerging in Big Pharma Since 2001, 300,000 pharma employees have lost their jobs, primarily in R D and sales. That’s according to Clifford Mintz, the founder of BioInsights, which develops and offers bioscience education and training. Mintz spoke at a session on new job opportunities in biotech and pharma at the annual AAPS meeting in Washington, D.C. While the losses have been steep, they’re balanced by emerging, in-demand careers in the industry. The industry’s struggles are well-known: Many companies are facing loss of exclusivity on their biggest sellers but have little in the …


The Challenges Facing Emerging Markets Generic Pharmaceutical Companies #pharmaceutical #healthcare #companies

Posted On Aug 10 2017 by

#generic pharmaceutical companies # Additional Information: The Challenges Facing Emerging Markets Generic Pharmaceutical Companies By Thomas Ansen-Wilson The US generic drug market has been quite lucrative for EM pharma companies over the last decade. Many EM pharma companies have significantly outperformed the market by leveraging solid technological capabilities and low manufacturing costs. However, the future looks more difficult as a number of changes in the US market have made the landscape increasingly challenging. In the past, when there were fewer players in the market, the first few firms to launch a generic drug were able to generate profits for a …